Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State
Clinical trial NCT03133468 · COMPLETED
Trial details
- NCT number
- NCT03133468
- Sponsor
- EA Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2018-07-06
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.